CClinicalTrials.gg
CompletedNCT04145908Updated Oct 31, 2019

Non Absorbable Mesh Reinforcement of Midline Incision Closure in High Risk Patients, Onlay Versus Preperitoneal Position, a Comparative Clinical Trial

An interventional study of midline mesh reinforcement in Midline Incisions, High Risk Patients and Mesh Reinforcement, sponsored by Zagazig University. Completed. Per ClinicalTrials.gov, last updated 2019-10-31.

Sponsored by Zagazig University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 3 years 3 months after the study started (first participant enrolled Jul 2016, registered Oct 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
47
Allocation
Randomized
Sex
All
01

Study summary

comparison between onlay and preperitoneal augmentation of mid line closure in high risk patients

Read the detailed description

This study is a randomized comparative clinical trial, carried out in the period from July 2016 to August, 2019, on 47 high-risk patients who are liable to develop incisional hernia, after elective abdominal operations through midline incisions.

High-risk patients means patients who had one or more of the factors that make them more liable to develop incisional hernia, as Obesity, Diabetes mellitus (DM), Steroid therapy, Liver diseases, Renal diseases, Cardiac diseases, Chest diseases , Malignancy, Nutritional deficiency and Old age.

Institutional Review Board, the ethical committee approved the study, determined the number of the study patients, all patients were informed and consented.

Randomization was carried out by assistant nurse using randomization computer program.

The patients were randomly divided into two groups:

  • Group I: wound closure is reinforced by onlay polypropylene mesh (24 patients)
  • Group II: wound closure is reinforced by preperitoneal polypropylene mesh (23 patients).

In both groups midline laparotomy was closed by non-absorbable continuous suture, 4\1 ratio reinforced with interrupted sutures every 4 bites.

All patients were subjected to: full history taking and clinical examination, radiological and laboratory investigations and endoscopy if needed.

SURGICAL TECHNIQUE In group I patients, after completion of the deemed surgery, the linea alba was closed as mentioned before, then the subcutaneous tissue was dissected of the anterior rectus sheath for 2 cm on both sides, then a polypropylene mesh strip 4 cm width and 4 cm longer than the wound length was applied and centered over the wound, fixed in the onlay position using prolene sutures 2\0. Suction drain is left in position, subcutaneous tissue and skin closed as per usual.

In group II patients, a preperitoneal pocket is created at the time of opening the mid line figure, linea alba is incised separately from peritoneum to facilitate formation of preperitoneal pocket , at time of closure, the mesh was inserted in the preperitoneal space after peritoneal closure with Vicryl 3\0 sutures, the mesh is fixed to the peritoneum by 4 stitches in the 4 quadrants , and to linea alba during midline closure , suction drain was left in the preperitoneal space.

Follow up Patients were followed up in outpatient clinic, (weekly for the first month then monthly for the first six months and lastly every 3 months for one year( in each visit they were carefully examined for any wound occurrences or hernia development, superficial probe ultrasonic examination of abdominal wall was done after 1 week and after 1 month. Demographic data, preoperative, operative and follow up data was collected tabulated and analyzed using SPSS 22 program package.

02

Conditions studied

  • Midline Incisions
  • High Risk Patients
  • Mesh Reinforcement
  • Incisional Hernia

Keywords

  • midline reinforcement
  • incisional hernia
  • mesh
03

In context

Hernia

1,096 studies on the registry are indexed under Hernia; 132 are open to participants now.

This study's enrollment of 47 is below the median of 80 across 739 interventional studies indexed under Hernia.

Browse Hernia studies →

Lead sponsor

Zagazig University is the lead sponsor of 447 studies on the registry; 75 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Obesity
  • Diabetes mellitus (DM),
  • Steroid therapy,
  • Liver diseases,
  • Renal diseases,
  • Cardiac diseases, Chest diseases ,
  • Malignancy,
  • Nutritional deficiency
  • Old age

Exclusion criteria

Exclusion Criteria:

  • non risk factor
  • previous incisional hernia
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
47 participants (actual)

Study arms

  • Active comparator
    preperitoneal mesh

    patients underwent preperitoneal mesh mesh placement

    Procedure: midline mesh reinforcement

  • Active comparator
    onlay mesh

    patients underwent preperitoneal mesh mesh placement

    Procedure: midline mesh reinforcement

Interventions

  • Proceduremidline mesh reinforcement

    augmentation of midline closure by nonabsorbsble mesh

06

What researchers measure

Primary outcomes

  1. midline incisional hernia ,

    clinical and ultrasound examination of the abdomen for incisional hernia development

    Time frame: weekly for one month , then monthly for 6 months then every 3 months later on till one year

Secondary outcomes

  1. post operative complications

    hematoma , seroma, wound infection by clinical examination and\\or ultrasound

    Time frame: (1st month post operative

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 31, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04145908
Lead sponsor
Zagazig University
Responsible party
Hazem Nour Abdellatif (Assistant professor, Zagazig University) — Principal investigator
First posted
Oct 31, 2019
Start date
Jul 2016
Primary completion
Aug 2019
Completion
Aug 2019
Last update
Oct 31, 2019

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion